创业慧康科技股份有限公司监事会 关于公司 2025 年员工持股计划相关事项的核查意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国 证券法》（以下简称"《证券法》"）《关于上市公司实施员工持股计划试点的指导 意见》（以下简称"《指导意见》"）及《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》（以下简称"《规范运作》"）等有关法律、行 政法规、规范性文件及《公司章程》的有关规定，创业慧康科技股份有限公司（以 下简称"公司"或"创业慧康"）监事会对公司 2025 年员工持股计划相关事项进 行了认真核查，现发表如下意见： 1、公司不存在《公司法》《证券法》《指导意见》等法律法规和规范性文件所 禁止实施员工持股计划的情形。 2、公司制定《创业慧康科技股份有限公司 2025 年员工持股计划（草案）》（以 下简称"本次员工持股计划"）的程序合法、有效。本次员工持股计划及其摘要的 内容符合《公司法》《证券法》《指导意见》等有关法律法规和规范性文件的规定， 不存在损害公司及全体股东利益的情形。 创业慧康科技股份有限公司 监事会 2025 年 9 月 24 日 3、公司审议本 ...

证券代码：300451 证券简称：创业慧康 公告编号：2025-048 创业慧康科技股份有限公司 第八届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"或"本公司"）第八届董事 会第十八次会议的通知于 2025 年 9 月 17 日以邮件、电话等方式向各位董事发出， 会议于 2025 年 9 月 23 日在公司三楼会议室以现场与通讯相结合的方式召开。会 议应到董事 11 名，实到董事 11 名，公司部分监事、高级管理人员列席了会议。 会议的召开及表决符合《中华人民共和国公司法》《创业慧康科技股份有限公司 章程》（以下简称"《公司章程》"）等有关规定。 此次会议由董事长张吕峥先生主持，参会董事认真审议后，依照有关规定通 过以下几项决议： 一、审议通过了《关于〈创业慧康科技股份有限公司 2025 年员工持股计划 （草案）〉及其摘要的议案》 公司依据《中华人民共和国公司法》《中华人民共和国证券法》《关于上市 公司实施员工持股计划试点的指导意见》等有关法律、行政法规、规章、规范 性文件和《公司章程》 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 通过天眼查大数据分析，创业慧康科技股份有限公司共对外投资了58家企业，参与招投标项目7820次； 财产线索方面有商标信息65条，专利信息114条，著作权信息715条；此外企业还拥有行政许可74个。 数据来源：天眼查APP 证券之星消息，根据天眼查APP-财产线索数据整理，根据南京市溧水区卫生健康委员会月9日17发布的 《2025年溧水区智慧医疗项目软件维保服务成交公告》内容显示，创业慧康科技股份有限公司中标，详 情如下： 标题：2025年溧水区智慧医疗项目软件维保服务成交公告 采购方：南京市溧水区卫生健康委员会 供应商：创业慧康科技股份有限公司 中标金额：602000.0 地区：江苏省 发布日期：2025-09-17 ...

专委会首批聘任来自全国各大医院、医疗机构的36位医疗信息化领域权威专家，并为卫宁健康 （300253）、东华医为、创业慧康（300451）、智业软件等23家成员单位颁发证书，引聚"行业大 咖"与"同行伙伴"，推动医疗AI从技术研发到临床落地的全过程创新，以跨界融合、协同发展的开放平 台推动医疗AI自主创新的"光合作用"。 经济观察网9月18日，在苏州昆山举办的"医疗人工智能自主创新之路"专题研讨会上，光合组织医卫专 委会正式成立。据悉，该专委会将汇聚生态伙伴力量，为医疗国产化与AI自主创新搭建更坚实的合作 平台、打通更高效的转化通道。 ...

Core Viewpoint - The stock of Chuangye Huikang (300451) has experienced a decline, with significant net outflows from major funds, indicating potential concerns about its financial performance and market sentiment [1][2]. Financial Performance - As of September 18, 2025, Chuangye Huikang's stock closed at 5.03 yuan, down 1.95%, with a trading volume of 477,800 hands and a turnover of 243 million yuan [1]. - The company reported a total revenue of 577 million yuan for the first half of 2025, a year-on-year decrease of 20.65%, and a net profit attributable to shareholders of -80.55 million yuan, a decline of 394.25% [3]. - The second quarter of 2025 saw a single-quarter revenue of 286 million yuan, down 18.48%, and a net profit of -64.91 million yuan, a decrease of 532.25% [3]. Market Position - Chuangye Huikang's total market capitalization is 7.792 billion yuan, with a net asset value of 4.407 billion yuan, and a net profit margin of -12.54% [3]. - The company ranks 82nd in total market value and 166th in net profit within the software development industry [3]. Investment Sentiment - In the last 90 days, three institutions have given buy ratings for Chuangye Huikang, with an average target price of 6.37 yuan [4]. - On September 18, 2025, the net outflow of major funds was 13.38 million yuan, accounting for 5.51% of the total turnover, while retail investors saw a net inflow of 7.57 million yuan, representing 3.12% of the total turnover [1][2].

Group 1 - The Ministry of Commerce and nine other departments have released policies to expand service consumption, focusing on easing market access in high-end medical and leisure vacation sectors to attract foreign and private investment [1] - The initiative aims to increase the supply of quality services and cultivate international markets in healthcare and exhibitions [1] - Analysts suggest that the expansion of the medical sector will create significant business opportunities in medical information technology and smart healthcare services [1] Group 2 - Companies such as Chuangshi Huikang and Langma Information are identified as relevant concepts in the A-share market related to the new policies [1]

Core Viewpoint - The company is transitioning from a traditional IT product supplier to a cloud ecosystem enterprise that provides intelligent medical data services, driven by the need for efficiency in the healthcare industry [1][2]. Industry Transformation - The healthcare information industry is shifting from "system construction" to "data-driven value creation," focusing on long-term cloud services, data value extraction, and open ecosystem collaboration [2]. - The company has established a data-first advantage by forming strategic partnerships and accumulating extensive medical data, including over 1 million structured medical terms and relationships [2]. Product Development and Market Response - The company has developed the Hi-HIS management information system, which has seen a 200% increase in project deliveries in the first half of the year, with significant deployments in various regions [3]. - The MedCopilot intelligent assistant, built on the BsoftGPT model, significantly reduces documentation time and improves efficiency in clinical settings [4]. Technological Collaboration - The company is addressing challenges in computational power and high-quality medical data by collaborating with major tech firms and academic institutions to create a dynamic AI dataset [5][6]. - A joint laboratory with Zhejiang University aims to convert cutting-edge AI technologies into practical solutions for clinical problems, enhancing the synergy between research and application [6]. Future Aspirations - The company aims to deepen the integration of AI with clinical practices, enhance the value of medical data, and promote equitable healthcare through technology [7]. - The management emphasizes a structured talent development approach, ensuring a smooth transition of leadership and responsibilities across generations [7].

● 本报记者罗京 在张吕峥看来，医疗卫生行业具有高度的专业性，涉及大量的专业术语和复杂的医疗流程。要落地AI 应用需要积累大量的医疗变量需求，包括诊断、药品、治疗、护理等场景，以便构建能够理解和处理医 疗数据的AI模型。"公司基于BsoftGPT大模型服务平台开发的智能医生助手MedCopilot，已成为临床医 护的'智能副驾'。" 据介绍，MedCopilot围绕临床高频需求构建能力：在病历文书生成上，能自动抽取病程记录、检查报告 等信息，将出院小结撰写时间从30分钟压缩至5分钟；在医疗质控环节，实时提醒"诊断编码错误、手术 记录缺失"等问题，效率提升60%。"从数十家落地医院反馈看，医护人员终于能从繁琐文书中解脱，把 时间还给患者。"张吕峥说。 从早期推动医疗信息化联网，到如今向"智能云生态企业"转型，成立于1997年的创业慧康（300451）， 在医疗信息化行业已深耕近三十年，见证了行业从单机系统到网络化、从信息化到智能化的全过程。 "当前行业已进入全新的'效率竞争'阶段。"创业慧康董事长张吕峥近日接受中国证券报记者专访时表 示，公司始终以医疗业务痛点为导向，通过构建开放的云生态平台"慧康云3.0"，积 ...

● 本报记者 罗京 从早期推动医疗信息化联网，到如今向"智能云生态企业"转型，成立于1997年的创业慧康，在医疗信息 化行业已深耕近三十年，见证了行业从单机系统到网络化、从信息化到智能化的全过程。 "我们与全国数千家医疗机构共同成长，深刻理解医生、护士及管理者在临床一线的实际痛点。这种理 解使我们能够将数据转化为真正有价值的智能应用，比如公司自主研发的多态智联大型医疗机构（集 团）管理信息系统Hi-HIS，"张吕峥介绍。上半年，公司Hi-HIS系统的交付进度与市场认可度显著提 升，完成36个项目交付，同比增长200%，并在苏州、阿克苏等地实现大规模部署。 AI覆盖医疗信息化全业务链路 "当前行业已进入全新的'效率竞争'阶段。"创业慧康董事长张吕峥近日接受中国证券报记者专访时表 示，公司始终以医疗业务痛点为导向，通过构建开放的云生态平台"慧康云3.0"，积极布局AI和数据要 素，正从单纯的IT产品供应商转变为能够持续为医疗机构乃至医药、保险行业提供医疗数据智能服务的 云生态企业。 在张吕峥看来，医疗卫生行业具有高度的专业性，涉及大量的专业术语和复杂的医疗流程。要落地AI 应用需要积累大量的医疗变量需求，包括诊断 ...

Core Viewpoint - The stock of Chuangye Huikang (300451) has shown fluctuations in trading volume and capital flow, with a notable decline in revenue and profit in the recent financial report, indicating potential challenges ahead for the company [1][3]. Group 1: Stock Performance - As of September 11, 2025, Chuangye Huikang closed at 5.1 yuan, up 0.79%, with a turnover rate of 2.89% and a trading volume of 441,800 hands, amounting to a transaction value of 222.3 million yuan [1]. - The net outflow of main funds on September 11 was 10.63 million yuan, accounting for 4.76% of the total transaction value, while retail investors saw a net inflow of 9.43 million yuan, representing 4.23% of the total [1][2]. Group 2: Financial Performance - For the first half of 2025, Chuangye Huikang reported a main revenue of 577 million yuan, a year-on-year decrease of 20.65%, and a net profit attributable to shareholders of -80.55 million yuan, down 394.25% [3]. - The company's second-quarter results showed a main revenue of 286 million yuan, a decline of 18.48%, and a net profit of -64.91 million yuan, a drop of 532.25% [3]. - The company has a total market value of 7.901 billion yuan, with a net asset of 4.407 billion yuan, and a net profit margin of -12.54% [3]. Group 3: Industry Comparison - Chuangye Huikang's price-to-earnings ratio is -49.04, compared to the software development industry average of 79.58, indicating a significant disparity in profitability metrics [3]. - The company's gross margin stands at 51.45%, which is higher than the industry average of 44.49%, suggesting better cost management in terms of production [3]. Group 4: Analyst Ratings - In the last 90 days, three institutions have given buy ratings for Chuangye Huikang, with an average target price of 6.37 yuan [4].